| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $387.5M | +65.8% |
| Cost of Revenue | $239.8M | +106.6% |
| Gross Profit | $147.6M | +25.5% |
| R&D Expense | $36.2M | +6.0% |
| SG&A Expense | $68.2M | +35.5% |
| Operating Income | -$23.0M | -125.9% |
| Pre-tax Income | -$16.5M | -77.3% |
| Income Tax | $1.5M | -89.4% |
| Net Income | -$17.9M |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $84.0M | -28.1% |
| Short-term Investments | $26.9M | -25.9% |
| Accounts Receivable | $70.8M | +56.2% |
| Inventory | $96.2M | +81.1% |
| Current Assets | $325.7M | +12.9% |
| Total Assets | $444.7M | -3.5% |
| Current Liabilities | $70.4M | +3.4% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$47.2M | -33.4% |
| Capital Expenditures | $6.8M | -81.5% |
| Investing Cash Flow | $21.1M | +483.3% |
| Financing Cash Flow | -$3.8M | -35.9% |
| Free Cash Flow | -$54.0M | +25.0% |
| +22.0% |
| EPS (Basic) | -$0.25 | +21.9% |
| EPS (Diluted) | -$0.25 | +21.9% |
| Total Liabilities |
| $81.1M |
| +0.8% |
| Stockholders' Equity | $363.6M | -4.4% |